Lasertherapy for Vulvodynia
ConditionVulvodynia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorMedical University of Graz
About this trial
The study aims to assess the efficacy, acceptance and safety profile of vulvovaginal laser therapy in women with vulvodynia.
Eligibility criteria
Qualifiers
Women with vulvodynia (diagnosed according to the 2015 Consensus Terminology)
multidisciplinary treatment for at least 3 months
Informed consent
Disqualifiers
Current genital infection (i.e. candidiasis, herpes )
Inflammatory vulvar disease/ dermatosis (i.e. lichen sclerosus, lichen planus)
Neoplastic vulvar disease (e.g. HSIL Vulva, Paget disease)
Recent vulvar trauma (i.e. bleeding, erosion or ulceration)
Trial design
Treatments tested in this trial
- Erbium:Yag laser
- Sham Erbium:Yag laser
Treatment groups
92 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov